
Doxofylline Tablet/ Syrup Suppliers & Bulk Manufacturers
Available Forms: Tablet & Syrup
Available Strengths: Tab: 200 mg, 400 mg; Syrup: 100 mg/5 mL
Reference Brands: Doxolin®, Respiridox®(India)
Category: Respiratory Disorder
Doxofylline tablet/ syrup is available in Tablet & Syrup and strengths such as Tab: 200 mg, 400 mg; Syrup: 100 mg/5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doxofylline tablet/ syrup is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Doxofylline tablet/ syrup can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Doxofylline Tablet is a modern bronchodilator used to treat asthma, chronic bronchitis, and COPD. It belongs to the methylxanthine class but offers better tolerability and fewer side effects compared to theophylline. Doxofylline works by relaxing airway muscles, improving airflow, and easing symptoms like wheezing and breathlessness. Commonly available in India in 200 mg and 400 mg strengths, it is sold under trusted brands like Doxolin®, Synasma®, Doxovent®, and Respiridox®. Though not FDA-approved in the US, it is widely prescribed in India and other countries for long-term respiratory management. It is available in tablet and syrup forms.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Oxomemazine
Strength:
0.33 mg/mL, 1.65 mg, 2.5 mg
Form: Syrup/ Tablet
Reference Brands: Oroxin (EU), Oxfezin
View DetailsErdosteine
Strength:
300mg, 175 mg/5 mL
Form: Tablets / Capsules / oral suspension
Reference Brands: Erdotin (EU), Esteclin (EU)
View DetailsVarenicline
Strength:
0.5 mg, 1 mg
Form: Tablets
Reference Brands: Chantix (USA), Champix(EU/UK)
View DetailsQuick Response Guaranteed | Verified Suppliers